Background: We provided updated cancer mortality estimates for 2026 in the European Union (EU) and its five most populous countries, with a focus on lung cancer. Methods: Cancer death certifications and population data were obtained from the World Health Organization and United Nations databases. For the EU, France, Germany, Italy, Poland, Spain and the UK we derived data for all cancers combined and major cancer sites since 1970. Linear regression models, based on the most recent age-specific trends identified by Poisson joinpoint regression, were used to estimate deaths in 2026. The number of averted deaths between 1989 and 2026 was computed by applying the 1988 peak rate to subsequent populations. Results: For 2026, we estimated about 1,230,000 EU cancer deaths, corresponding to age-standardised rates of 114.1/100,000 males (-7.8% vs 2020-2022) and 74.7/100,000 females (-5.9%). In the EU countries and the whole EU, favourable trends are predicted for most major cancers, except female pancreatic cancer. In the UK, predicted rates are also favourable, except female colorectal cancer. Lung cancer mortality continues to decrease markedly among males, while we predicted a levelling off of rates - around 12.5/100,000 - among females in all considered countries and the whole EU, except for Spain (+2.4%). Among females, lung cancer mortality declines are confined to those <65 years, while unfavourable trends continued in older age groups. Around 7.3 million total cancer deaths have been avoided in the EU since the peak observed in 1988. The corresponding figure for lung cancer is 1.8 million among males, while no averted deaths were recorded among females. Conclusion: Lung cancer mortality predictions for 2026 indicate a levelling off among EU females, with age- and country-specific differences. Mortality trends in ASRs for most cancers remain favourable in the EU and the UK, though the absolute number of cancer deaths is not declining due to population ageing.

Santucci, C., Mignozzi, S., Levi, F., Malvezzi, M., Boffetta, P., Negri, E., et al. (2026). European cancer mortality predictions for the year 2026: the levelling of female lung cancer mortality. ANNALS OF ONCOLOGY, 30, 1-10 [10.1016/j.annonc.2025.12.005].

European cancer mortality predictions for the year 2026: the levelling of female lung cancer mortality

Levi, F;Malvezzi, M;Boffetta, P;
2026

Abstract

Background: We provided updated cancer mortality estimates for 2026 in the European Union (EU) and its five most populous countries, with a focus on lung cancer. Methods: Cancer death certifications and population data were obtained from the World Health Organization and United Nations databases. For the EU, France, Germany, Italy, Poland, Spain and the UK we derived data for all cancers combined and major cancer sites since 1970. Linear regression models, based on the most recent age-specific trends identified by Poisson joinpoint regression, were used to estimate deaths in 2026. The number of averted deaths between 1989 and 2026 was computed by applying the 1988 peak rate to subsequent populations. Results: For 2026, we estimated about 1,230,000 EU cancer deaths, corresponding to age-standardised rates of 114.1/100,000 males (-7.8% vs 2020-2022) and 74.7/100,000 females (-5.9%). In the EU countries and the whole EU, favourable trends are predicted for most major cancers, except female pancreatic cancer. In the UK, predicted rates are also favourable, except female colorectal cancer. Lung cancer mortality continues to decrease markedly among males, while we predicted a levelling off of rates - around 12.5/100,000 - among females in all considered countries and the whole EU, except for Spain (+2.4%). Among females, lung cancer mortality declines are confined to those <65 years, while unfavourable trends continued in older age groups. Around 7.3 million total cancer deaths have been avoided in the EU since the peak observed in 1988. The corresponding figure for lung cancer is 1.8 million among males, while no averted deaths were recorded among females. Conclusion: Lung cancer mortality predictions for 2026 indicate a levelling off among EU females, with age- and country-specific differences. Mortality trends in ASRs for most cancers remain favourable in the EU and the UK, though the absolute number of cancer deaths is not declining due to population ageing.
2026
Santucci, C., Mignozzi, S., Levi, F., Malvezzi, M., Boffetta, P., Negri, E., et al. (2026). European cancer mortality predictions for the year 2026: the levelling of female lung cancer mortality. ANNALS OF ONCOLOGY, 30, 1-10 [10.1016/j.annonc.2025.12.005].
Santucci, C; Mignozzi, S; Levi, F; Malvezzi, M; Boffetta, P; Negri, E; La Vecchia, C
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/1045955
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact